Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia

NCT00002120 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia, Pneumocystis Carinii
HIV Infections

Interventions

DRUG: Trimetrexate glucuronate
DRUG: Trimethoprim
DRUG: Sulfamethoxazole
DRUG: Dapsone
DRUG: Leucovorin calcium

Sponsor

U.S. Bioscience

Collaborators

[object Object]